Cerebro NeuroTech
Developer of AI and spatial computing software for early detection and assessment of neurocognitive disease, focused on rapid detection of traumatic brain injury (TBI). The technology is in a research/beta testing phase and is explicitly not FDA-cleared for commercial distribution; intended for research use only.
Industries
Nr. of Employees
small (1-50)
Products
Rapid detection software for traumatic brain injury (research use)
An AI- and spatial-computing-based software intended to rapidly detect signs of traumatic brain injury for research and early-assessment workflows. Not cleared for commercial clinical use in the U.S.
AI/ML neural network research device
Research-stage neural network system developed for neurocognitive disease detection and algorithm development; explicitly labeled for research use only and not FDA-cleared.
Rapid detection software for traumatic brain injury (research use)
An AI- and spatial-computing-based software intended to rapidly detect signs of traumatic brain injury for research and early-assessment workflows. Not cleared for commercial clinical use in the U.S.
AI/ML neural network research device
Research-stage neural network system developed for neurocognitive disease detection and algorithm development; explicitly labeled for research use only and not FDA-cleared.
Services
Beta testing and research collaborations
Program to enroll research users for evaluation and iterative development of research-use diagnostic software and devices.
Beta testing and research collaborations
Program to enroll research users for evaluation and iterative development of research-use diagnostic software and devices.
Expertise Areas
- Digital health diagnostics
- AI/ML for medical imaging and assessment
- Traumatic brain injury detection
- Neurocognitive disease assessment
Key Technologies
- Machine learning neural networks
- Spatial computing
- AI-driven diagnostics
- Digital health software platforms